Jean‐Frédéric Colombel

687 papers receiving 59.0k citations

Jean‐Frédéric Colombel's Hit Papers

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease 2023 · 247 citations
2470+3+7Years since publication50010001.5k2.0k2.5k

Peers

Jean‐Frédéric Colombel
Comparison fields: 5 of 163
  • Genetics 38.4k
  • Gastroenterology 3.9k
  • Epidemiology 16.5k
  • Immunology 8.3k
  • Surgery 9.0k
Replace Séverine Vermeire with:
Séverine Vermeire Belgium
Paul Rutgeerts Belgium
Silvio Danese Italy
Stephan R. Targan United States
Laurent Peyrin‐Biroulet France
Bruce E. Sands United States
Brian G. Feagan Canada
Stephen B. Hanauer United States
Geert D’Haens Netherlands
William J. Sandborn United States
Jean‐Frédéric Colombel relative to Séverine Vermeire Belgium Séverine Vermeire's profile →
Citations per field
00.5×1.5×
Séverine Vermeire · 1×
Citations per year

Countries citing papers authored by Jean‐Frédéric Colombel

Since Specialization
Citations

This map shows the geographic impact of Jean‐Frédéric Colombel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Frédéric Colombel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Frédéric Colombel more than expected).

Fields of papers citing papers by Jean‐Frédéric Colombel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Frédéric Colombel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Frédéric Colombel. The network helps show where Jean‐Frédéric Colombel may publish in the future.

Co-authors

The 25 scholars most cited alongside Jean‐Frédéric Colombel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jean‐Frédéric Colombel Line = papers co-authored together Jean‐Frédéric Colombel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 722 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hit paper breakdown →
20023209
2
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Hit paper breakdown →
20052951
3
Ulcerative colitis
Hit paper breakdown →
20162614
4
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Hit paper breakdown →
20102316
5
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Hit paper breakdown →
20132090
6
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Hit paper breakdown →
20132052
7
Crohn's disease
Hit paper breakdown →
20161844
8
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Hit paper breakdown →
20211627
9
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
Hit paper breakdown →
20101139
10
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
Hit paper breakdown →
2011961
11
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
Hit paper breakdown →
2016755
12
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Hit paper breakdown →
2009749
13
CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel Disease
Hit paper breakdown →
2002746
14
Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab
Hit paper breakdown →
2007743
15
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease
Hit paper breakdown →
2004740
16
Mapping of a susceptibility locus for Crohn's disease on chromosome 16
Hit paper breakdown →
1996726
17
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
Hit paper breakdown →
2013713
18
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Hit paper breakdown →
2011695
19
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
Hit paper breakdown →
2005690
20
The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients
Hit paper breakdown →
2003673

About Jean‐Frédéric Colombel

Jean‐Frédéric Colombel is a scholar working on Genetics, Epidemiology, Surgery, Immunology and Gastroenterology, having authored 722 papers that have together received 60.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (502 papers), Microscopic Colitis (177 papers), Eosinophilic Esophagitis (53 papers), Immunodeficiency and Autoimmune Disorders (41 papers), Autoimmune and Inflammatory Disorders (36 papers), Helicobacter pylori-related gastroenterology studies (35 papers), Celiac Disease Research and Management (30 papers) and Gut microbiota and health (27 papers). The work is most often cited by research in Genetics (38.4k citations), Gastroenterology (3.9k citations), Epidemiology (16.5k citations), Immunology (8.3k citations) and Surgery (9.0k citations). Jean‐Frédéric Colombel has collaborated with scholars based in United States, France and Canada. Frequent co-authors include William J. Sandborn, Laurent Peyrin‐Biroulet, Paul Rutgeerts, Brian G. Feagan, Saurabh Mehandru, Bruce E. Sands, Ryan C. Ungaro, Daniel Rachmilewitz, Stephen B. Hanauer and Walter Reinisch. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, Inflammatory Bowel Diseases, The American Journal of Gastroenterology and Clinical Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact